255 related articles for article (PubMed ID: 8133075)
1. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N
J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075
[TBL] [Abstract][Full Text] [Related]
2. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
3. Recombinant antibodies against ganglioside expressed on tumor cells.
Hanai N; Nakamura K; Shitara K
Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against camel (Camelus dromedarius) IgG, IgM and light chains.
Azwai SM; Carter SD; Woldehiwet Z
Vet Immunol Immunopathol; 1995 Mar; 45(1-2):175-84. PubMed ID: 7604534
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
Sanai Y; Yamasaki M; Nagai Y
Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
[TBL] [Abstract][Full Text] [Related]
6. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Kitamura K; Livingston PO; Fortunato SR; Stockert E; Helling F; Ritter G; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2805-9. PubMed ID: 7708728
[TBL] [Abstract][Full Text] [Related]
7. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
Ohta S; Igarashi S; Honda A; Sato S; Hanai N
Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
[TBL] [Abstract][Full Text] [Related]
9. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
[TBL] [Abstract][Full Text] [Related]
10. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).
Young WW; MacDonald EM; Nowinski RC; Hakomori SI
J Exp Med; 1979 Oct; 150(4):1008-19. PubMed ID: 512581
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterisation of murine monoclonal antibodies specific for cervine immunoglobulin light chain, IgM and IgG.
Hibma M; Griffin JF
Vet Immunol Immunopathol; 1992 Mar; 31(3-4):267-78. PubMed ID: 1589954
[TBL] [Abstract][Full Text] [Related]
13. Variations in the secretion of monoclonal antibodies by human-human hybridomas.
Gaffar SA; Surh CD; Glassy MC
Hybridoma; 1986; 5(2):93-105. PubMed ID: 3721525
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal equine IgM and IgG immunoglobulins.
Wagner B; Radbruch A; Richards C; Leibold W
Vet Immunol Immunopathol; 1995 Jul; 47(1-2):1-12. PubMed ID: 8533286
[TBL] [Abstract][Full Text] [Related]
15. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
16. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R
Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986
[TBL] [Abstract][Full Text] [Related]
18. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
[No Abstract] [Full Text] [Related]
19. Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.
Reitan SK; Hannestad K
Proc Natl Acad Sci U S A; 2002 May; 99(11):7588-93. PubMed ID: 12032327
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]